507486 — Caprolactam Chemicals Income Statement
0.000.00%
- IN₹207.69m
- IN₹278.37m
- IN₹69.57m
- 28
- 16
- 40
- 14
Annual income statement for Caprolactam Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 65.1 | 63.1 | 20.7 | 98.4 | 69.6 |
Cost of Revenue | |||||
Gross Profit | 64.9 | 63 | 15.4 | 92.3 | 64.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 50.1 | 52.1 | 36.7 | 63.2 | 63.7 |
Operating Profit | 15 | 11 | -16 | 35.2 | 5.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 12.6 | 8.91 | -14.7 | 29.7 | 2.72 |
Provision for Income Taxes | |||||
Net Income After Taxes | 9.51 | 6.51 | -12.8 | 25.5 | 1.97 |
Net Income Before Extraordinary Items | |||||
Net Income | 9.51 | 6.51 | -12.8 | 25.5 | 1.97 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9.51 | 6.51 | -12.8 | 25.5 | 1.97 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.07 | 1.41 | -2.79 | 5.54 | 0.429 |
Dividends per Share |